We are studying a new combination of medications for patients with heart attacks in critical condition. The goal is to see if this treatment can prevent blood clots while keeping bleeding risks low.
Health conditions and diseases that the clinical trial is designed to study and treat.
Cardiogenic shock is a life-threatening condition where the heart fails to pump enough blood to the body, often resulting from a severe heart attack or other heart conditions. It requires immediate medical attention and can lead to organ failure if not treated promptly.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.